Radiation Research

Clinical Research. The Lacks Cancer Center’s Department of Radiation Oncology is taking part in several research studies to develop newer and safer methods of delivering radiation therapy. These clinical research trials are being conducted in partnership with such groups as the Van Andel Institute and College of Human Medicine at Michigan State University. In addition, our Radiation Oncology department is an honored member of The National Cancer Institute (NCI) supported Radiation Therapy Oncology Group (RTOG)—a national association that supports worldwide clinical trials that establish the standards of care in radiation therapy.

Saint Mary's also regularly conducts research and clinical trials in conjunction with the Grand Rapids Clinical Oncology Program (GRCOP), a group that establishes standards of care in radiation therapy, with support from from the National Cancer Institute (NCI) Community Clinical Oncology Program (CCOP). This means that we partner with 300 physicians to access almost 150 cancer research studies for patients living in 38 counties. We also take part in such basic research trials as testing our patients sensitivity to radiation therapy. By gauging their susceptibility to the side effects of radiation therapy we can further tailor treatments that meet each individual's needs.

If you would like to know if you qualify for an RTOG trial contact Dr. Padula's office at (616) 752-6218.

MammoSite/Partial Breast Radiation (PBI) Trial. The Lacks Cancer Center, in collaboration with the RTOG, is the only Grand Rapids area institution that participates in clinical trials in the use of MammoSite/PBI to breast cancer patients. This trial is designed to test whether PBI (radiation therapy that treats only the portion of breast where the tumor is located) is a safe alternative to conventional whole breast radiation. Typically, PBI is offered either through a MammoSite balloon device—a balloon that is inserted into the cavity and delivers high-dose radiation twice daily—or from a linear accelerator, a machine that delivers radiation to the entire breast. Both therapies are given over a one-week period, as opposed to a typical six-week course of radiation therapy. The decision to enroll patients in this trial is typically made after a consultation with a radiation oncologist and surgeon.

Breast Cancer patients who are interested in joining this clinical trial should contact Dr. Gil Padula's office at (616) 752-6218.